Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J. Kerr

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Science Translational Medicine|July 16, 2010
Quinone oxidoreductase-2-mediated prodrug cancer therapyMark R Middleton, Richard Knox, Emma Cattell, et al.
The EMBO Journal|February 14, 2012
Arginine methylation controls growth regulation by E2F-1Er-Chieh Cho, Shunsheng Zheng, Shonagh Munro, et al.
The Lancet. Oncology|August 14, 2022
A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation studyAndreas Kleppe, Ole-Johan Skrede, Sepp De Raedt, et al.
The New England Journal of Medicine|March 19, 2004
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancerJohn P Neoptolemos, Deborah D Stocken, Helmut Friess, et al.
The Lancet. Oncology|February 7, 2018
Chromatin organisation and cancer prognosis: a pan-cancer studyAndreas Kleppe, Fritz Albregtsen, Ljiljana Vlatkovic, et al.
Cell|December 17, 2025
Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinomaZhaomin Deng, Lu Pu, Kai Deng, et al.
Clinical and Experimental Pharmacology & Physiology|November 30, 2004
Nitroreductase: a prodrug-activating enzyme for cancer gene therapyPeter F Searle, Ming-Jen Chen, Longqin Hu, et al.
International Journal of Oncology|May 9, 2009
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancerLeonard W Seymour, David R Ferry, David J Kerr, et al.
The Oncologist|April 5, 2022
The Essentials of MultiomicsJohn L Marshall, Beth N Peshkin, Takayuki Yoshino, et al.
JCO Global Oncology|September 30, 2020
Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global WebinarsAbdul Rahman Jazieh, Stephen L Chan, Giuseppe Curigliano, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Science Translational Medicine|July 16, 2010
Quinone oxidoreductase-2-mediated prodrug cancer therapyMark R Middleton, Richard Knox, Emma Cattell, et al.
The EMBO Journal|February 14, 2012
Arginine methylation controls growth regulation by E2F-1Er-Chieh Cho, Shunsheng Zheng, Shonagh Munro, et al.
The Lancet. Oncology|August 14, 2022
A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation studyAndreas Kleppe, Ole-Johan Skrede, Sepp De Raedt, et al.
The New England Journal of Medicine|March 19, 2004
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancerJohn P Neoptolemos, Deborah D Stocken, Helmut Friess, et al.
The Lancet. Oncology|February 7, 2018
Chromatin organisation and cancer prognosis: a pan-cancer studyAndreas Kleppe, Fritz Albregtsen, Ljiljana Vlatkovic, et al.
Cell|December 17, 2025
Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinomaZhaomin Deng, Lu Pu, Kai Deng, et al.
Clinical and Experimental Pharmacology & Physiology|November 30, 2004
Nitroreductase: a prodrug-activating enzyme for cancer gene therapyPeter F Searle, Ming-Jen Chen, Longqin Hu, et al.
International Journal of Oncology|May 9, 2009
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancerLeonard W Seymour, David R Ferry, David J Kerr, et al.
The Oncologist|April 5, 2022
The Essentials of MultiomicsJohn L Marshall, Beth N Peshkin, Takayuki Yoshino, et al.
JCO Global Oncology|September 30, 2020
Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global WebinarsAbdul Rahman Jazieh, Stephen L Chan, Giuseppe Curigliano, et al.
Pageof 9